Dr. Chris Baldwin is the Chief Executive Officer and Managing Director of HaemaLogiX.
Dr Rosanne Dunn is an Executive Director and the Chief Scientific Officer at HaemaLogiX, and was a Co-Founder of the Company and has been a Director since the Company's incorporation.
Kerem Kaya is the Chief Financial Officer and Co-Company Secretary at HaemaLogiX and commenced with the Company in March 2024.
Professor Mohamad Hussein is Chief Medical Advisor at HaemaLogiX and has held academic, clinical, and pharmaceutical leadership roles focused on hematologic malignancies, especially multiple myeloma.
Halley Hilton brings over 25 years of clinical and operational experience in pharmaceutical and biotech industries across multiple therapeutic areas.
